Cargando…

Permitting patients to pay for participation in clinical trials: the advent of the P4 trial

In this article we explore the ethical issues raised by permitting patients to pay for participation (P4) in clinical trials, and discuss whether there are any categorical objections to this practice. We address key considerations concerning payment for participation in trials, including patient aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, David, de Wert, Guido, Dondorp, Wybo, Townend, David, Bos, Gerard, van Gelder, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487744/
https://www.ncbi.nlm.nih.gov/pubmed/27757784
http://dx.doi.org/10.1007/s11019-016-9741-2
Descripción
Sumario:In this article we explore the ethical issues raised by permitting patients to pay for participation (P4) in clinical trials, and discuss whether there are any categorical objections to this practice. We address key considerations concerning payment for participation in trials, including patient autonomy, risk/benefit and justice, taking account of two previous critiques of the ethics of P4. We conclude that such trials could be ethical under certain strict conditions, but only if other potential sources of funding have first been explored or are unavailable.